These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30196643)

  • 1. [The clinical performance of high risk HPV DNA test among triage women with cytology showing atypical squamous cells of undetermined significance].
    Zhang SK; Zhao DM; Chen HM; Guo Z; Ren LY; Jia MM; Chang JJ; Chen PP; Liu SZ; Sun XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Sep; 52(9):941-945. PubMed ID: 30196643
    [No Abstract]   [Full Text] [Related]  

  • 2. Performance of HPV16/18 in Triage of Cytological Atypical Squamous Cells of Undetermined Significance.
    Cao X; Liu S; Jia M; Chen H; Zhao D; Dong B; Guo Z; Ren L; Zhang S; Sun X
    Anal Cell Pathol (Amst); 2019; 2019():4324710. PubMed ID: 31934532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE; Reid J; Dockter J; Getman D
    J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of CCNA1 promoter methylation in triaging ASC-US cytology.
    Oranratanaphan S; Kobwitaya K; Termrungruanglert W; Triratanachat S; Kitkumthorn N; Mutirangura A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):473-477. PubMed ID: 32102526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China.
    Pan D; Dong B; Gao H; Mao X; Xue H; Sun P
    Risk Manag Healthc Policy; 2020; 13():1747-1756. PubMed ID: 33061708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions.
    El-Zein M; Bouten S; Abdrabo LS; Siblini A; Louvanto K; Franco E; Ferenczy A
    J Low Genit Tract Dis; 2023 Jan; 27(1):12-18. PubMed ID: 36205321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results.
    Isidean SD; Mayrand MH; Ramanakumar AV; Rodrigues I; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):923-929. PubMed ID: 28096198
    [No Abstract]   [Full Text] [Related]  

  • 12. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.
    Schiffman M; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Apple R; Aldrich C; Erlich HA; Tam T; Befano B; Burk RD; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1304-10. PubMed ID: 26088703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
    Castle PE; Eaton B; Reid J; Getman D; Dockter J
    J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer.
    Xu L; Verdoodt F; Wentzensen N; Bergeron C; Arbyn M
    Cancer Cytopathol; 2016 Apr; 124(4):261-72. PubMed ID: 26618614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
    Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
    Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Performance of high-risk HPV typing test in early diagnosis of cervical cancer].
    Wang P; Guo Z; Zhao DM; Xu HF; Jia MM; Ren LY; Chen PP; Sun XY; Li MJ; Sun XB; Qiao YL; Zhang SK
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(18):1396-1400. PubMed ID: 32392990
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cervical cancer screening with primary HPV-DNA test in the Local Health Authority 2 of Savona (Liguria Region, Northern Italy): a population-based study].
    Depetrini E; Bonelli L; Ardoino S; Cirucca MC; Contin R; De Leonardis D; Errigo V; Lugani A; Franco A; Pastorino A; Carrozzi G; Venturino E
    Epidemiol Prev; 2016; 40(3-4):171-8. PubMed ID: 27436250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.
    Tao X; Austin RM; Yu T; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Apr; 130(4):248-258. PubMed ID: 34874615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.